HIV vaccines: Plan B

linkurl:Anthony Fauci,;http://www.the-scientist.com/article/display/13734/ director of NIH's National Institute of Allergies and Infectious Diseases (NIAID), is apparently making good on the promise to "turn the knob towards discovery" in HIV vaccine research, which he made at a linkurl:meeting;http://www.the-scientist.com/blog/display/54488/ this March. The NIAID today (May 20) linkurl:announced;http://www.nih.gov/news/health/may2008/niaid-20.htm a five-year, $15.6 million project to fund rese

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
linkurl:Anthony Fauci,;http://www.the-scientist.com/article/display/13734/ director of NIH's National Institute of Allergies and Infectious Diseases (NIAID), is apparently making good on the promise to "turn the knob towards discovery" in HIV vaccine research, which he made at a linkurl:meeting;http://www.the-scientist.com/blog/display/54488/ this March. The NIAID today (May 20) linkurl:announced;http://www.nih.gov/news/health/may2008/niaid-20.htm a five-year, $15.6 million project to fund research that aims to elicit the production of broad linkurl:neutralizing antibodies;http://www.the-scientist.com/article/home/39377/ from linkurl:B cells;http://www.the-scientist.com/article/display/19841/ instead of targeting linkurl:T cells;http://www.the-scientist.com/article/display/20089/ - the approach taken by linkurl:previous vaccine efforts.;http://www.the-scientist.com/blog/display/53633/ "This program reflects our commitment to probe the fundamental science underlying HIV vaccine development," Fauci said in an NIAID release. "The study of B cells and broadly neutralizing antibodies to HIV will answer pressing, basic scientific questions and bring greater balance to our portfolio of HIV vaccine discovery research." The 10 research groups funded through the program include investigators at the Scripps Research Institute, the University of California, Irvine, and Weill Cornell Medical College. According to the NIAID, the teams will share data and resources in their quest for a B cell-focused vaccine.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
Image of people clinking glasses with various alcoholic beverages at a table.
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
An illustration of colorful shapes.

Real-Time Image-Enabled Cell Sorting 

BD
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
Wastewater surveillance conceptual visualization of a water droplet containing different microorganism

Elevating Wastewater Epidemiology with Microfluidics

Products

Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits

Cytosurge Logo

Cytosurge Announces Strategic Leadership Transition